Wake-promoting Agents
Wake-Promoting Agents is a class of pharmacological compounds that, as a genus, enhance central nervous system arousal, and, as distinguished by their specific mechanism of action, selectively target neurochemical pathways to promote sustained wakefulness in individuals with hypersomnolence disorders.
98
Publications
7K
Citations
586
Authors
197
Institutions
Publications per year
2017–2026
26
Variants
Wake-promoting DrugsWake-promoting Medications
98
Dopaminergic Role in Stimulant-Induced Wakefulness
Jonathan P. Wisor, Seiji Nishino, Ichiro Sora et al. · Journal of Neuroscience · 2001 · 762 citations · Full text
Effects of Modafinil on Dopamine and Dopamine Transporters in the Male Human Brain
Nora D. Volkow, Joanna S. Fowler, Jean Logan et al. · JAMA · 2009 · 527 citations · Full text
Medicine, Neuroscience, Pharmacology +17
Yves Dauvilliers, Johan Verbraecken, Markku Partinen et al. · American Journal of Respiratory and Critical Care Medicine · 2020 · 265 citations · Full text
1–5 of 98
586
9
h-index
7
h-index
7
h-index
5
h-index
5
h-index
1–5 of 586
197
Inserm
Paris, France
8 h-index
21 publications
1.7K citations
Stanford University
Stanford, United States
7 h-index
19 publications
4.1K citations
Jazz Pharmaceuticals (United States)
Palo Alto, United States
6 h-index
17 publications
1K citations

Centre National de la Recherche Scientifique
Paris, France
6 h-index
23 publications
1.7K citations
Université Claude Bernard Lyon 1
Villeurbanne, France
4 h-index
9 publications
618 citations
National Institute on Drug Abuse
Bethesda, United States
4 h-index
21 publications
10.7K citations
Takeda (Japan)
Osaka, Japan
4 h-index
40 publications
1.8K citations
National Institutes of Health
Bethesda, United States
4 h-index
9 publications
3.3K citations
1–8 of 197
10 publications · 723 citations
10
h-index
6 publications · 419 citations
6
h-index
4 publications · 430 citations
4
h-index
4 publications · 55 citations
4
h-index
3 publications · 1K citations
3
h-index
1–5